Seth Sandesh (CIK 0001566175)

Latest company ownership

Shares held
184,481
Last filed at
Aug 20, 2025
Confidence Score
48.6
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
123,258
Last filed at
Dec 17, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 18, 2025 Aug 20, 2025 Actinium Pharmaceuticals, Inc. CEO Sell 42.5 -120,900 -39.59% ✗ $206.7K
Dec 10, 2018 Dec 10, 2018 Actinium Pharmaceuticals, Inc. CEO Buy 85.0 +10,000 6.98% ✗ $4.4K
Jul 17, 2018 Jul 17, 2018 Actinium Pharmaceuticals, Inc. CEO Buy 85.0 +10,000 7.50% ✗ $7.9K
Apr 19, 2018 Apr 20, 2018 Actinium Pharmaceuticals, Inc. CEO Buy 82.5 +5,000 3.90% ✗ $1.9K
Mar 6, 2018 Mar 8, 2018 Actinium Pharmaceuticals, Inc. CEO Buy 91.3 +52,500 69.23% ✗ $26.3K
Aug 2, 2017 Aug 4, 2017 Actinium Pharmaceuticals, Inc. CEO Buy 91.3 +33,333 78.43% ✗ $25K
Jun 15, 2017 Jun 15, 2017 Actinium Pharmaceuticals, Inc. CEO Buy 90.0 +7,500 10.34% ✗ $8.7K
Dec 30, 2016 Jan 3, 2017 Actinium Pharmaceuticals, Inc. Chair Buy 90.0 +5,000 16.67% ✗ $4.4K
Dec 12, 2016 Dec 12, 2016 Actinium Pharmaceuticals, Inc. Chair Buy 90.0 +5,000 20.00% ✗ $4.9K
Apr 14, 2016 Apr 18, 2016 Actinium Pharmaceuticals, Inc. Director Buy 91.3 +15,000 150.00% ✗ $29.9K
Dec 15, 2015 Dec 17, 2015 RELMADA THERAPEUTICS, INC. Director Buy 86.3 +9,500 8.35% ✗ $30.3K
Dec 14, 2015 Dec 16, 2015 RELMADA THERAPEUTICS, INC. Director Buy 91.3 +10,500 10.17% ✗ $30.7K